Menu
Stock Lookup
Search by symbol or company name, then inspect the chart and stock properties.
US
LGND Ligand Pharmaceuticals Incorporated
TradingView
As Of 6/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
254.5400
Day %
-1.27%
RS
83
RS 1D
84
RS 1W
82
RS 1M
77
RS 3M
85
RS 6M
86
Consensus Rating
Buy
Current Quarter EPS
1.01
Next Quarter EPS
1.20
Current Year EPS
5.47
Next Year EPS
6.63
ExchangeUS
Market Cap4 B
52W High259.0300
From 52W High-1.73%
Open254.9900
High259.0300
Low250.4900
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-06-12
Bars Available309
Scanner Hits25
Last Scanner Hit2026-06-11
Recent Scanner History
25 matching / 25 total| Date | Scanner | RS |
|---|---|---|
| 2026-06-11 |
Pocket Pivot
US_POCKET_PIVOT
|
84 |
| 2026-06-09 |
Setup Scan
US_SETUP
|
83 |
| 2026-06-04 |
Setup Scan
US_SETUP
|
78 |
| 2026-06-02 |
Setup Scan
US_SETUP
|
77 |
| 2026-06-01 |
Setup Scan
US_SETUP
|
77 |
| 2026-05-26 |
Setup Scan
US_SETUP
|
81 |
| 2026-05-22 |
Pocket Pivot
US_POCKET_PIVOT
|
79 |
| 2026-05-22 |
Setup Scan
US_SETUP
|
79 |
| 2026-05-21 |
Setup Scan
US_SETUP
|
78 |
| 2026-05-20 |
Setup Scan
US_SETUP
|
77 |
Analyst Snapshot
As Of 3/29/26| Consensus | Current Quarter EPS | Next Quarter EPS | Current Year EPS | Next Year EPS |
|---|---|---|---|---|
| Buy | 1.01 | 1.20 | 5.47 | 6.63 |
Based on 4 analysts offering recommendations for 'LGND'.
Quarterly EPS Forecasts
4 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Mar 2026 | 1.01 | 1.37 | 0.63 | 3 |
▲
1
▼
1
|
| Jun 2026 | 1.20 | 1.40 | 1.07 | 3 |
▲
0
▼
2
|
| Sep 2026 | 1.35 | 1.50 | 1.20 | 3 |
▲
0
▼
0
|
| Dec 2026 | 1.41 | 1.57 | 1.27 | 3 |
▲
0
▼
0
|
Yearly EPS Forecasts
4 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | 5.47 | 7.10 | 4.42 | 4 |
▲
2
▼
2
|
| Dec 2027 | 6.63 | 8.36 | 4.97 | 4 |
▲
2
▼
2
|
| Dec 2028 | 6.09 | 6.86 | 5.31 | 2 |
▲
0
▼
0
|
| Dec 2029 | 7.04 | 8.40 | 5.68 | 2 |
▲
0
▼
0
|